治疗前全免疫炎症值能否预测食管癌患者的生存情况？ - Suppr

Could Pretreatment Pan‑Immune‑Inflammation Value Predict Survival in Esophageal Cancer?

作者信息

Shen Yi, Chen Longqi, Che Guowei

机构信息

Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Department of Thoracic Surgery/Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

出版信息

Ann Surg Oncol. 2024 Jun;31(6):3868-3869. doi: 10.1245/s10434-024-15100-7. Epub 2024 Mar 9.

DOI:10.1245/s10434-024-15100-7

PMID:38461194

Abstract

摘要

相似文献

Could Pretreatment Pan‑Immune‑Inflammation Value Predict Survival in Esophageal Cancer?

Ann Surg Oncol. 2024 Jun;31(6):3868-3869. doi: 10.1245/s10434-024-15100-7. Epub 2024 Mar 9.

Reply to Letter to the Editor Regarding "Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?".

Ann Surg Oncol. 2024 Jun;31(6):3870-3871. doi: 10.1245/s10434-024-15101-6. Epub 2024 Feb 23.

Inflammatory markers correlate with lymphocytes infiltrating and predict immunotherapy prognosis for esophageal cancer.

Future Oncol. 2024 Dec;20(39):3267-3278. doi: 10.1080/14796694.2024.2421151. Epub 2024 Nov 12.

The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature.

World J Surg Oncol. 2018 Mar 14;16(1):55. doi: 10.1186/s12957-018-1357-y.

Advances in prognostic biomarkers for esophageal cancer.

Expert Rev Mol Diagn. 2019 Feb;19(2):109-119. doi: 10.1080/14737159.2019.1563485. Epub 2018 Dec 30.

Concomitant Expression of Inhibitory Molecules for T cell Activation Predicts Poor Survival in Patients with Esophageal Squamous Cell Carcinoma.

Curr Cancer Drug Targets. 2021;21(3):244-253. doi: 10.2174/1568009620666201120152333.

Prognostic and clinicopathological significance of fibronectin expression in esophageal carcinoma.

Asian J Surg. 2024 Aug;47(8):3538-3540. doi: 10.1016/j.asjsur.2023.09.173. Epub 2023 Oct 11.

Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.

BMC Cancer. 2016 Nov 11;16(1):877. doi: 10.1186/s12885-016-2940-7.

Prognostic value of the standardized uptake value in esophageal cancer.

AJR Am J Roentgenol. 2005 Aug;185(2):436-40. doi: 10.2214/ajr.185.2.01850436.

Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.

BMC Cancer. 2021 Sep 3;21(1):988. doi: 10.1186/s12885-021-08728-1.

引用本文的文献

Prognostic and Predictive Value of Pan-Immune Inflammation Value in Rectal Cancer Patients Treated With Neoadjuvant Therapy.

Cancer Control. 2025 Jan-Dec;32:10732748251361684. doi: 10.1177/10732748251361684. Epub 2025 Jul 15.

Association of pan-immune inflammation value and lung health in adults.

BMC Pulm Med. 2025 Jan 14;25(1):18. doi: 10.1186/s12890-025-03493-4.

本文引用的文献

Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.

Ann Surg Oncol. 2024 Jan;31(1):272-283. doi: 10.1245/s10434-023-14430-2. Epub 2023 Oct 14.

Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer.

Ann Surg Open. 2021 Dec 22;3(1):e113. doi: 10.1097/AS9.0000000000000113. eCollection 2022 Mar.

Clinical utility of preoperative pan-immune-inflammation value (PIV) for prognostication in patients with esophageal squamous cell carcinoma.

Int Immunopharmacol. 2023 Oct;123:110805. doi: 10.1016/j.intimp.2023.110805. Epub 2023 Aug 15.

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.

Thorac Cancer. 2023 Jun;14(17):1556-1566. doi: 10.1111/1759-7714.14898. Epub 2023 Apr 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Could Pretreatment Pan‑Immune‑Inflammation Value Predict Survival in Esophageal Cancer?

作者信息

Shen Yi, Chen Longqi, Che Guowei

机构信息

Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Department of Thoracic Surgery/Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

出版信息

Ann Surg Oncol. 2024 Jun;31(6):3868-3869. doi: 10.1245/s10434-024-15100-7. Epub 2024 Mar 9.

DOI:10.1245/s10434-024-15100-7

PMID:38461194

Abstract

摘要

相似文献

Could Pretreatment Pan‑Immune‑Inflammation Value Predict Survival in Esophageal Cancer?

Ann Surg Oncol. 2024 Jun;31(6):3868-3869. doi: 10.1245/s10434-024-15100-7. Epub 2024 Mar 9.

Reply to Letter to the Editor Regarding "Could Pretreatment Pan-Immune-Inflammation Value Predict Survival in Esophageal Cancer?".

Ann Surg Oncol. 2024 Jun;31(6):3870-3871. doi: 10.1245/s10434-024-15101-6. Epub 2024 Feb 23.

Inflammatory markers correlate with lymphocytes infiltrating and predict immunotherapy prognosis for esophageal cancer.

Future Oncol. 2024 Dec;20(39):3267-3278. doi: 10.1080/14796694.2024.2421151. Epub 2024 Nov 12.

The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature.

World J Surg Oncol. 2018 Mar 14;16(1):55. doi: 10.1186/s12957-018-1357-y.

Advances in prognostic biomarkers for esophageal cancer.

Expert Rev Mol Diagn. 2019 Feb;19(2):109-119. doi: 10.1080/14737159.2019.1563485. Epub 2018 Dec 30.

Concomitant Expression of Inhibitory Molecules for T cell Activation Predicts Poor Survival in Patients with Esophageal Squamous Cell Carcinoma.

Curr Cancer Drug Targets. 2021;21(3):244-253. doi: 10.2174/1568009620666201120152333.

Prognostic and clinicopathological significance of fibronectin expression in esophageal carcinoma.

Asian J Surg. 2024 Aug;47(8):3538-3540. doi: 10.1016/j.asjsur.2023.09.173. Epub 2023 Oct 11.

Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.

BMC Cancer. 2016 Nov 11;16(1):877. doi: 10.1186/s12885-016-2940-7.

Prognostic value of the standardized uptake value in esophageal cancer.

AJR Am J Roentgenol. 2005 Aug;185(2):436-40. doi: 10.2214/ajr.185.2.01850436.

Prognostic impact of tumor length in esophageal Cancer: a systematic review and Meta-analysis.

BMC Cancer. 2021 Sep 3;21(1):988. doi: 10.1186/s12885-021-08728-1.

引用本文的文献

Prognostic and Predictive Value of Pan-Immune Inflammation Value in Rectal Cancer Patients Treated With Neoadjuvant Therapy.

Cancer Control. 2025 Jan-Dec;32:10732748251361684. doi: 10.1177/10732748251361684. Epub 2025 Jul 15.

Association of pan-immune inflammation value and lung health in adults.

BMC Pulm Med. 2025 Jan 14;25(1):18. doi: 10.1186/s12890-025-03493-4.

本文引用的文献

Pretreatment Pan-Immune-Inflammation Value (PIV) in Predicting Therapeutic Response and Clinical Outcomes of Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma.

Ann Surg Oncol. 2024 Jan;31(1):272-283. doi: 10.1245/s10434-023-14430-2. Epub 2023 Oct 14.

Pan-immune-inflammation Value and Prognosis in Patients With Esophageal Cancer.

Ann Surg Open. 2021 Dec 22;3(1):e113. doi: 10.1097/AS9.0000000000000113. eCollection 2022 Mar.

Clinical utility of preoperative pan-immune-inflammation value (PIV) for prognostication in patients with esophageal squamous cell carcinoma.

Int Immunopharmacol. 2023 Oct;123:110805. doi: 10.1016/j.intimp.2023.110805. Epub 2023 Aug 15.

Thorac Cancer. 2023 Jun;14(17):1556-1566. doi: 10.1111/1759-7714.14898. Epub 2023 Apr 24.

Could Pretreatment Pan‑Immune‑Inflammation Value Predict Survival in Esophageal Cancer?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Could Pretreatment Pan‑Immune‑Inflammation Value Predict Survival in Esophageal Cancer?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献